What serious adverse reactions happened during this study?
The most common serious adverse reaction was a type of lung infection called
pneumonia.
Most common serious adverse reactions
Relapsed/Refractory Treatment-Na√Øve
Serious adverse reaction (out of 32 participants) (out of 16 participants)
A type of lung infection called
6.3% (2) 0.0% (0)
pneumonia
Fever with low numbers of a
type of white blood cell called 3.1% (1) 0.0% (0)
neutrophils
Bad bruising 3.1% (1) 0.0% (0)
Headache 3.1% (1) 0.0% (0)
Liver failure 3.1% (1) 0.0% (0)
Sudden increase in hepatitis B
3.1% (1) 0.0% (0)
virus
Fungal infection in the lungs 3.1% (1) 0.0% (0)
A type of cancer called
3.1% (1) 0.0% (0)
adenocarcinoma in the lungs
A type of cancer called myeloma
in a type of white blood cell called 3.1% (1) 0.0% (0)
plasma cells
A type of cancer called carcinoma
3.1% (1) 0.0% (0)
in kidney cells
A type of cancer called carcinoma
in a type of skin cell called 3.1% (1) 0.0% (0)
squamous cells
Bleeding in the upper part of the
0.0% (0) 6.3% (1)
stomach and gut
There was 1 participant who had relapsed/refractory leukemia who died because of a
serious adverse reaction. This serious adverse reaction was liver failure.
12 | Clinical Study Results